Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.
Industry, Sector and Symbol:
- Sector: Multi-Sector Conglomerates
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: Industrial Conglomerates
- Symbol: NYSE:DHR
- CUSIP: 23585110
- Web: www.danaher.com
Capitalization:- Market Cap: $60.29 billion
- Outstanding Shares: 694,689,000
Average Prices:- 50 Day Moving Avg: $82.99
- 200 Day Moving Avg: $84.20
- 52 Week Range: $75.71 - $88.62
P/E:- Trailing P/E Ratio: 27.70
- Foreward P/E Ratio: 20.23
- P/E Growth: 2.49
Sales & Book Value:- Annual Revenue: $17.43 billion
- Price / Sales: 3.46
- Book Value: $35.40 per share
- Price / Book: 2.45
Dividend:- Annual Dividend: $0.56
- Dividend Yield: 0.7%
Profitability:- EBIDTA: $4.16 billion
- Net Margins: 12.63%
- Return on Equity: 11.15%
- Return on Assets: 5.95%
Debt:- Debt-to-Equity Ratio: 0.46%
- Current Ratio: 1.49%
- Quick Ratio: 1.06%
Misc:- Average Volume: 2.88 million shs.
- Beta: 1.03
- Short Ratio: 1.21
Frequently Asked Questions for Danaher Corporation (NYSE:DHR)
What is Danaher Corporation's stock symbol?
Danaher Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
How often does Danaher Corporation pay dividends? What is the dividend yield for Danaher Corporation?
Danaher Corporation declared a quarterly dividend on Tuesday, September 12th. Shareholders of record on Friday, September 29th will be given a dividend of $0.14 per share on Friday, October 27th. This represents a $0.56 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. View Danaher Corporation's Dividend History.
How were Danaher Corporation's earnings last quarter?
Danaher Corporation (NYSE:DHR) issued its quarterly earnings data on Thursday, July, 20th. The company reported $0.99 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.97 by $0.02. The firm earned $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.90 EPS. View Danaher Corporation's Earnings History.
When will Danaher Corporation make its next earnings announcement?
What guidance has Danaher Corporation issued on next quarter's earnings?
Danaher Corporation issued an update on its FY17 earnings guidance on Thursday, July, 20th. The company provided EPS guidance of $3.90-3.97 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.93. Danaher Corporation also updated its Q3 guidance to $0.92-0.96 EPS.
Where is Danaher Corporation's stock going? Where will Danaher Corporation's stock price be in 2017?
14 analysts have issued 1 year target prices for Danaher Corporation's shares. Their predictions range from $88.00 to $97.00. On average, they anticipate Danaher Corporation's share price to reach $92.75 in the next year. View Analyst Ratings for Danaher Corporation.
What are analysts saying about Danaher Corporation stock?
Here are some recent quotes from research analysts about Danaher Corporation stock:
- 1. According to Zacks Investment Research, "Danaher kept its impressive earnings beat streak alive as its second-quarter 2017 adjusted earnings beat the Zacks Consensus Estimate by 2.1%. The company has an excellent earnings history over the trailing four quarters, beating estimates all through. We are optimistic about the company’s core revenue and earnings growth, on the back of improving order trends and its operating culture, DBS. Going forward, the company expects the biopharma business to be a major growth driver. Its recent acquisitions - Pall and Cepheid – are proving to be strong profit churners, and will boost top-line growth as they become a part of the company’s core revenues. Year to date, the stock has yielded a positive retur compared to the the industry's average decline. However, on the flip side, slowdown in the company’s academic business in Europe and prolonged sluggishness in the Dental business might restrict growth, going forward." (7/28/2017)
- 2. Jefferies Group LLC analysts commented, "Following a solid 4Q beat, our '17 forecasts feel incrementally conservative, given strong core margin progress & encouraging signs of better demand in certain industrial pockets. With core growth poised to accelerate in '17 (and '18) & ample margin expansion levers on-hand, we maintain our Buy rating." (2/1/2017)
- 3. Evercore ISI analysts commented, "DHR delivered a quarter generally consistent with expectations as core growth remains on an upward trajectory, OMx is solid given the flurry of deals over the past 24 months and FCF conversion is elevated (another form of synergy capture from M&A). We believe investors have aptly rewarded the result, with today's move in shares indicative of a flee to safety and predictability in what is otherwise a challenging Healthcare tape. Given potential cyclical upside should global GDP growth accelerate and a reasonably strong B/S to continue capital allocation in 2017 and beyond we believe DHR's elevated valuation is justified and thus it remains our 'Top Pick' within a Tools complex we favor overall. Furthermore, we believe that while the Dental market has proven frustrating, the asset is of high quality and long-term investors will be pleased to either see the business generate improved / superior returns or be monetized (via sale / spin) for more than is implied in current valuation." (1/31/2017)
Who are some of Danaher Corporation's key competitors?
Some companies that are related to Danaher Corporation include Thermo Fisher Scientific (TMO), Boston Scientific Corporation (BSX), Koninklijke Philips NV (PHG), Intuitive Surgical (ISRG), Illumina (ILMN), Edwards Lifesciences Corp (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR), Quidel (QDEL) and Accelerate Diagnostics (AXDX).
Who are Danaher Corporation's key executives?
Danaher Corporation's management team includes the folowing people:
- Steven M. Rales, Chairman of the Board
- Daniel L. Comas, Chief Financial Officer, Executive Vice President
- Rainer M. Blair, Executive Vice President
- William K. Daniel II, Executive Vice President
- Robert S. Lutz, Senior Vice President, Chief Accounting Officer
- Brian W. Ellis, Senior Vice President, General Counsel
- Angela S. Lalor, Senior Vice President - Human Resources
- William H. King, Senior Vice President - Strategic Development
- Daniel A. Raskas, Senior Vice President - Corporate Development
- Thomas Patrick Joyce Jr., President, Chief Executive Officer, Director
Who owns Danaher Corporation stock?
Danaher Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.97%), BlackRock Inc. (5.64%), FMR LLC (2.82%), Northern Trust Corp (1.30%), Bank of New York Mellon Corp (0.97%) and Flossbach Von Storch AG (0.83%). Company insiders that own Danaher Corporation stock include Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, James A Lico, Linda P Hefner, Robert S Lutz, Thomas Patrick Joyce Jr, Thomas Patrick Joyce, Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher Corporation.
Who sold Danaher Corporation stock? Who is selling Danaher Corporation stock?
Danaher Corporation's stock was sold by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, Bank of New York Mellon Corp, Capital Guardian Trust Co., Alliancebernstein L.P., TIAA CREF Investment Management LLC, Macquarie Group Ltd., Montag & Caldwell LLC and APG Asset Management N.V.. Company insiders that have sold Danaher Corporation stock in the last year include Angela S Lalor, Brian W Ellis, Donald J Ehrlich, Linda P Hefner, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher Corporation.
Who bought Danaher Corporation stock? Who is buying Danaher Corporation stock?
Danaher Corporation's stock was bought by a variety of institutional investors in the last quarter, including Flossbach Von Storch AG, Arrowstreet Capital Limited Partnership, Koch Industries Inc., HealthCor Management L.P., BlackRock Inc., Cramer Rosenthal Mcglynn LLC, Vanguard Group Inc. and UBS Oconnor LLC. View Insider Buying and Selling for Danaher Corporation.
How do I buy Danaher Corporation stock?
Shares of Danaher Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Danaher Corporation's stock price today?
One share of Danaher Corporation stock can currently be purchased for approximately $86.78.
MarketBeat Community Rating for Danaher Corporation (NYSE DHR)MarketBeat's community ratings are surveys of what our community members think about Danaher Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Danaher Corporation (NYSE:DHR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 11 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.79) |
| Consensus Price Target: | $92.75 (6.88% upside) |
Analysts' Ratings History for Danaher Corporation (NYSE:DHR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/8/2017 | J P Morgan Chase & Co | Reiterated Rating | Overweight | $95.00 | Low |  |
| 8/4/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $95.00 | Low | |
| 7/22/2017 | Wells Fargo & Co | Reiterated Rating | Market Perform | | Low | |
| 7/21/2017 | Citigroup Inc. | Set Price Target | Buy | $98.00 -> $96.00 | Low | |
| 7/12/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $88.00 | Low | |
| 6/21/2017 | Deutsche Bank AG | Reiterated Rating | Buy | $97.00 | Low | |
| 6/7/2017 | Janney Montgomery Scott | Downgrade | Buy -> Neutral | | Low | |
| 5/24/2017 | Credit Suisse Group | Reiterated Rating | Buy | $93.00 | Low | |
| 4/23/2017 | William Blair | Reiterated Rating | Outperform | | Low | |
| 4/23/2017 | Cowen and Company | Reiterated Rating | Outperform | $90.00 | Low | |
| 4/23/2017 | BTIG Research | Reiterated Rating | Buy | $92.00 | Low | |
| 1/31/2017 | Evercore ISI | Boost Price Target | Buy | $88.50 -> $91.50 | N/A | |
| 12/15/2016 | Sanford C. Bernstein | Reiterated Rating | Outperform | | N/A | |
| 12/13/2016 | Morgan Stanley | Reiterated Rating | Overweight | | N/A | |
| 9/7/2016 | Barclays PLC | Boost Price Target | Overweight | $90.00 -> $91.00 | N/A | |
| 7/28/2016 | Argus | Reiterated Rating | Buy | $110.00 -> $90.00 | N/A | |
| 7/5/2016 | Goldman Sachs Group, Inc. (The) | Initiated Coverage | Neutral | $74.00 | N/A | |
| 5/29/2016 | Bank of America Corporation | Reiterated Rating | Buy | | N/A | |
| 4/25/2016 | Leerink Swann | Reiterated Rating | Buy | | N/A | |
| 4/25/2016 | Sterne Agee CRT | Boost Price Target | Neutral | $90.00 -> $97.00 | N/A | |
| 4/22/2016 | Stifel Nicolaus | Boost Price Target | Buy | $109.00 -> $110.00 | N/A | |
(Data available from 9/24/2015 forward)
Earnings History for Danaher Corporation (NYSE:DHR)Earnings History by Quarter for Danaher Corporation (NYSE DHR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/19/2017 | | $0.95 | | | | | N/A | |
| 7/20/2017 | Q2 2017 | $0.97 | $0.99 | $4.50 billion | $4.51 billion | View | N/A | |
| 4/20/2017 | Q1 2017 | $0.84 | $0.85 | $4.17 billion | $4.21 billion | View | N/A | |
| 1/31/2017 | Q416 | $1.03 | $1.05 | $4.54 billion | $4.60 billion | View | N/A | |
| 10/20/2016 | Q316 | $0.82 | $0.87 | $4.14 billion | $4.10 billion | View | Listen | |
| 7/25/2016 | Q216 | $1.22 | $1.25 | $5.76 billion | $5.80 billion | View | Listen | |
| 4/21/2016 | Q116 | $1.03 | $1.08 | $5.33 billion | $5.39 billion | View | Listen | |
| 1/26/2016 | Q415 | $1.27 | $1.27 | $6.03 billion | $5.88 billion | View | Listen | |
| 10/22/2015 | Q315 | $1.04 | $1.05 | $4.99 billion | $5.02 billion | View | Listen | |
| 7/23/2015 | Q215 | $1.04 | $1.08 | $5.07 billion | $5.13 billion | View | Listen | |
| 4/23/2015 | Q115 | $0.93 | $0.93 | $4.84 billion | $4.87 billion | View | Listen | |
| 1/27/2015 | Q414 | $1.04 | $1.04 | $5.39 billion | $5.42 billion | View | Listen | |
| 10/16/2014 | Q314 | $0.90 | $0.90 | $4.90 billion | $4.90 billion | View | Listen | |
| 7/17/2014 | Q214 | $0.94 | $0.95 | $4.97 billion | $5.00 billion | View | Listen | |
| 4/16/2014 | Q114 | $0.80 | $0.81 | $4.67 billion | $4.66 billion | View | Listen | |
| 1/28/2014 | Q413 | $0.95 | $0.96 | $5.20 billion | $5.27 billion | View | Listen | |
| 10/17/2013 | Q313 | $0.83 | $0.84 | $4.61 billion | $4.67 billion | View | Listen | |
| 7/18/2013 | Q2 2013 | $0.85 | $0.87 | $4.72 billion | $4.70 billion | View | Listen | |
| 4/18/2013 | Q1 2013 | $0.76 | $0.75 | $4.50 million | $4.40 million | View | Listen | |
| 1/29/2013 | Q4 2012 | $0.86 | $0.89 | $4.81 billion | $4.98 billion | View | Listen | |
| 10/18/2012 | | $0.79 | $0.77 | | | View | N/A | |
| 7/19/2012 | | $0.80 | $0.84 | | | View | N/A | |
| 4/19/2012 | | $0.71 | $0.73 | | | View | N/A | |
| 1/31/2012 | | $0.78 | $0.81 | | | View | N/A | |
| 10/20/2011 | | $0.70 | $0.73 | | | View | N/A | |
| 7/21/2011 | | $0.67 | $0.69 | | | View | N/A | |
| 4/21/2011 | | $0.57 | $0.65 | | | View | N/A | |
| 1/27/2011 | | $0.66 | $0.67 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Danaher Corporation (NYSE:DHR)2017 EPS Consensus Estimate: $3.93
2018 EPS Consensus Estimate: $4.33
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.84 | $0.84 | $0.84 |
| Q2 2017 | 2 | $0.96 | $0.99 | $0.98 |
| Q3 2017 | 2 | $0.95 | $0.95 | $0.95 |
| Q4 2017 | 2 | $1.16 | $1.17 | $1.17 |
| Q1 2018 | 1 | $1.01 | $1.01 | $1.01 |
| Q2 2018 | 1 | $1.08 | $1.08 | $1.08 |
| Q3 2018 | 1 | $1.06 | $1.06 | $1.06 |
| Q4 2018 | 1 | $1.18 | $1.18 | $1.18 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Danaher Corporation (NYSE:DHR)| Next Dividend: | 10/27/2017 |
| Annual Dividend: | $0.56 |
| Dividend Yield: | 0.65% |
| Dividend Growth: | 97.80% (3 Year Average) |
| Payout Ratio: | 17.83% (Trailing 12 Months of Earnings)
14.18% (Based on This Year's Estimates)
13.05% (Based on Next Year's Estimates)
|
| Track Record: | 3 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Danaher Corporation (NYSE DHR)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 9/12/2017 | quarterly | $0.14 | 0.64% | 9/28/2017 | 9/29/2017 | 10/27/2017 |
| 5/9/2017 | quarterly | $0.14 | 0.68% | 6/28/2017 | 6/30/2017 | 7/28/2017 |
| 2/21/2017 | quarterly | $0.14 | 0.66% | 3/29/2017 | 3/31/2017 | 4/28/2017 |
| 12/6/2016 | quarterly | $0.13 | 0.65% | 12/28/2016 | 12/30/2016 | 1/27/2017 |
| 9/13/2016 | quarterly | $0.13 | 0.65% | 9/28/2016 | 9/30/2016 | 10/28/2016 |
| 5/10/2016 | quarterly | $0.16 | 0.65% | 6/1/2016 | 6/3/2016 | 7/29/2016 |
| 2/23/2016 | quarterly | $0.16 | 0.73% | 3/22/2016 | 3/25/2016 | 4/29/2016 |
| 12/8/2015 | quarterly | $0.14 | 0.57% | 12/17/2015 | 12/21/2015 | 1/29/2016 |
| 9/16/2015 | quarterly | $0.14 | 0.61% | 9/23/2015 | 9/25/2015 | 10/30/2015 |
| 5/18/2015 | quarterly | $0.14 | 0.62% | 6/24/2015 | 6/26/2015 | 7/31/2015 |
| 2/25/2015 | quarterly | $0.14 | 0.62% | 3/25/2015 | 3/27/2015 | 4/24/2015 |
| 12/10/2014 | quarterly | $0.10 | 0.48% | 12/23/2014 | 12/26/2014 | 1/30/2015 |
| 9/9/2014 | quarterly | $0.10 | 0.52% | 9/24/2014 | 9/26/2014 | 10/31/2014 |
| 5/8/2014 | quarterly | $0.10 | 0.55% | 6/25/2014 | 6/27/2014 | 7/25/2014 |
| 12/12/2013 | quarterly | $0.03 | 0.13% | 12/26/2013 | 12/30/2013 | 1/31/2014 |
| 9/12/2013 | quarterly | $0.03 | 0.14% | 9/25/2013 | 9/27/2013 | 10/25/2013 |
| 5/22/2013 | quarterly | $0.03 | 0.16% | 6/26/2013 | 6/28/2013 | 7/26/2013 |
| 2/22/2013 | quarterly | $0.03 | 0.16% | 3/26/2013 | 3/28/2013 | 4/26/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Danaher Corporation (NYSE:DHR)Insider Ownership Percentage: 12.20%
Institutional Ownership Percentage: 75.68%
Insider Trades by Quarter for Danaher Corporation (NYSE:DHR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/31/2017 | William King | Insider | Sell | 43,688 | $82.86 | $3,619,987.68 | |
| 7/31/2017 | Thomas Patrick Joyce Jr | Insider | Sell | 9,772 | $81.78 | $799,154.16 | |
| 7/21/2017 | Linda P Hefner | Director | Sell | 10,578 | $83.03 | $878,291.34 | |
| 7/21/2017 | William King | Insider | Sell | 7,458 | $82.97 | $618,790.26 | |
| 5/23/2017 | Angela S Lalor | SVP | Sell | 10,815 | $84.16 | $910,190.40 | |
| 4/25/2017 | William K Daniel | EVP | Sell | 17,444 | $83.07 | $1,449,073.08 | |
| 4/21/2017 | Donald J Ehrlich | Director | Buy | 600 | $82.76 | $49,656.00 | |
| 4/21/2017 | Thomas Patrick Joyce Jr | Insider | Sell | 54,006 | $82.52 | $4,456,575.12 | |
| 2/28/2017 | Brian W Ellis | Insider | Sell | 983 | $86.00 | $84,538.00 | |
| 2/24/2017 | Robert S Lutz | SVP | Sell | 37,870 | $85.60 | $3,241,672.00 | |
| 2/15/2017 | Walter G Lohr | Director | Sell | 10,578 | $84.32 | $891,936.96 | |
| 2/14/2017 | Donald J Ehrlich | Director | Sell | 10,578 | $83.98 | $888,340.44 | |
| 10/21/2016 | Thomas Patrick Joyce Jr | Insider | Sell | 36,125 | $79.68 | $2,878,440.00 | |
| 8/1/2016 | Thomas Patrick Joyce Jr | Insider | Sell | 45,897 | $81.44 | $3,737,851.68 | |
| 7/27/2016 | Daniel L Comas | CFO | Sell | 96,446 | $80.88 | $7,800,552.48 | |
| 5/12/2016 | Angela S Lalor | SVP | Sell | 8,392 | $97.77 | $820,485.84 | |
| 4/27/2016 | James A Lico | EVP | Sell | 58,954 | $96.93 | $5,714,411.22 | |
| 4/22/2016 | Daniel L Comas | CFO | Sell | 89,280 | $95.71 | $8,544,988.80 | |
| 4/22/2016 | Thomas Patrick Joyce Jr | CEO | Sell | 14,630 | $95.50 | $1,397,165.00 | |
| 4/22/2016 | William K Daniel | EVP | Sell | 41,140 | $96.06 | $3,951,908.40 | |
| 4/22/2016 | William King | SVP | Sell | 6,000 | $96.31 | $577,860.00 | |
| 2/29/2016 | James A Lico | EVP | Sell | 60,000 | $89.24 | $5,354,400.00 | |
| 2/26/2016 | Daniel Raskas | SVP | Sell | 4,656 | $89.00 | $414,384.00 | |
| 2/26/2016 | Walter G Lohr | Director | Sell | 8,000 | $89.06 | $712,480.00 | |
| 2/10/2016 | Donald J. Ehrlich | Director | Sell | 8,000 | $86.00 | $688,000.00 | |
| 1/27/2016 | Thomas Patrick Joyce, Jr. | CEO | Sell | 25,300 | $83.98 | $2,124,694.00 | |
| 11/24/2015 | James A. Lico | EVP | Sell | 55,840 | $96.40 | $5,382,976.00 | |
| 10/30/2015 | William K. Daniel | EVP | Sell | 39,740 | $93.04 | $3,697,409.60 | |
| 10/23/2015 | Daniel L. Comas | CFO | Sell | 36,200 | $92.71 | $3,356,102.00 | |
| 10/23/2015 | Robert S. Lutz | CAO | Sell | 26,400 | $93.45 | $2,467,080.00 | |
| 10/23/2015 | Thomas Patrick Joyce, Jr. | CEO | Sell | 25,300 | $93.47 | $2,364,791.00 | |
| 7/24/2015 | Thomas Patrick Joyce Jr | CEO | Sell | 25,300 | $88.20 | $2,231,460.00 | |
| 7/24/2015 | William K Daniel | EVP | Sell | 15,000 | $88.40 | $1,326,000.00 | |
| 7/24/2015 | William King | SVP | Sell | 4,000 | $88.00 | $352,000.00 | |
| 5/28/2015 | Angela S Lalor | SVP | Sell | 5,959 | $87.06 | $518,790.54 | |
| 5/22/2015 | Walter G Lohr | Director | Sell | 8,000 | $87.00 | $696,000.00 | |
| 5/19/2015 | Jonathan P Graham | VP | Sell | 30,232 | $86.89 | $2,626,858.48 | |
| 5/15/2015 | Jonathan P Graham | VP | Sell | 185,620 | $87.73 | $16,284,442.60 | |
| 4/24/2015 | Daniel L Comas | CFO | Sell | 25,000 | $83.50 | $2,087,500.00 | |
| 4/24/2015 | Thomas Patrick Joyce Jr | CEO | Sell | 43,945 | $83.81 | $3,683,030.45 | |
| 4/24/2015 | William K Daniel | EVP | Sell | 58,400 | $83.33 | $4,866,472.00 | |
| 2/26/2015 | Daniel Raskas | SVP | Sell | 4,179 | $87.79 | $366,874.41 | |
| 2/24/2015 | Jonathan P Graham | VP | Sell | 9,961 | $86.77 | $864,315.97 | |
| 2/20/2015 | Daniel Raskas | SVP | Sell | 56,000 | $87.03 | $4,873,680.00 | |
| 2/3/2015 | Donald J Ehrlich | Director | Sell | 8,000 | $84.82 | $678,560.00 | |
| 2/2/2015 | James A Lico | EVP | Sell | 98,000 | $82.64 | $8,098,720.00 | |
| 2/2/2015 | Walter G Lohr | Director | Sell | 8,000 | $82.30 | $658,400.00 | |
| 1/28/2015 | Daniel L Comas | CFO | Sell | 75,000 | $84.59 | $6,344,250.00 | |
| 11/20/2014 | James H Ditkoff | VP | Sell | 3,606 | $82.35 | $296,954.10 | |
| 11/3/2014 | Thomas Patrick Joyce Jr | CEO | Sell | 50,000 | $79.97 | $3,998,500.00 | |
| 10/29/2014 | Angela S Lalor | SVP | Sell | 8,450 | $79.45 | $671,352.50 | |
| 8/1/2014 | William King | SVP | Sell | 3,545 | $73.74 | $261,408.30 | |
| 7/18/2014 | H Lawrence Culp Jr | CEO | Sell | 111,540 | $74.14 | $8,269,575.60 | |
| 5/28/2014 | John T Schwieters | Director | Sell | 8,000 | $78.73 | $629,840.00 | |
| 5/12/2014 | Jonathan Graham | VP | Sell | 9,973 | $75.00 | $747,975.00 | |
| 5/1/2014 | Daniel Raskas | SVP | Sell | 11,158 | $73.48 | $819,889.84 | |
| 2/25/2014 | Robert Lutz | CAO | Sell | 6,250 | $76.85 | $480,312.50 | |
| 10/24/2013 | Daniel L Comas | CFO | Sell | 50,000 | $71.65 | $3,582,500.00 | |
| 10/18/2013 | Daniel Raskas | SVP | Sell | 20,000 | $71.99 | $1,439,800.00 | |
| 8/29/2013 | Donald Ehrlich | Director | Sell | 8,000 | $65.25 | $522,000.00 | |
| 8/6/2013 | Thomas Patrick Joyce, Jr. | EVP | Sell | 48,000 | $67.04 | $3,217,920.00 | |
| 7/24/2013 | Daniel Raskas | SVP | Sell | 20,000 | $67.54 | $1,350,800.00 | |
| 7/22/2013 | Daniel L Comas | CFO | Sell | 54,540 | $68.14 | $3,716,355.60 | |
| 7/19/2013 | Robert S Lutz | CAO | Sell | 5,852 | $68.57 | $401,271.64 | |
| 7/1/2013 | James A Lico | EVP | Sell | 50,000 | $64.66 | $3,233,000.00 | |
| 5/21/2013 | Daniel L Comas | CFO | Sell | 55,000 | $63.89 | $3,513,950.00 | |
| 5/16/2013 | Walter G Lohr | Director | Sell | 8,000 | $62.72 | $501,760.00 | |
| 5/15/2013 | H Lawrence Culp Jr | CEO | Sell | 500,000 | $61.92 | $30,960,000.00 | |
| 5/13/2013 | James A Lico | EVP | Sell | 22,519 | $61.75 | $1,390,548.25 | |
| 2/25/2013 | Jonathan P Graham | VP | Sell | 7,295 | $61.38 | $447,767.10 | |
| 2/25/2013 | Thomas Patrick Joyce Jr | EVP | Sell | 20,723 | $61.24 | $1,269,076.52 | |
(Data available from 1/1/2013 forward)
Headline Trends for Danaher Corporation (NYSE:DHR)
Latest Headlines for Danaher Corporation (NYSE:DHR)
| Source: |
|
| Date | Headline |
|---|
 | Financial Survey: Danaher Corporation (DHR) versus Its Peers
www.americanbankingnews.com - September 22 at 8:20 PM |
 | Danaher Schedules Third Quarter 2017 Earnings Conference Call
finance.yahoo.com - September 20 at 6:41 PM |
| Zacks: Brokerages Anticipate Danaher Corporation (DHR) Will Announce Quarterly Sales of $4.46 Billion
www.americanbankingnews.com - September 14 at 3:46 AM |
| Zacks: Brokerages Expect Danaher Corporation (DHR) Will Announce Earnings of $0.95 Per Share
www.americanbankingnews.com - September 12 at 10:20 PM |
| Danaher Corporation Announces Quarterly Dividend of $0.14 (DHR)
www.americanbankingnews.com - September 12 at 4:44 PM |
 | Danaher Corporation declares $0.14 dividend
seekingalpha.com - September 12 at 4:21 PM |
| Financial Contrast: Danaher Corporation (DHR) & Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - September 11 at 6:44 PM |
 | Danaher Was Just Added To An Important JP Morgan List; Here's ... - Benzinga
www.benzinga.com - September 9 at 4:22 AM |
| Danaher Corporation (DHR) Given Overweight Rating at J P Morgan Chase & Co
www.americanbankingnews.com - September 8 at 10:34 PM |
| Danaher Was Just Added To An Important JP Morgan List; Here's Why
finance.yahoo.com - September 8 at 6:14 PM |
| Danaher Corp. – Value Analysis (NYSE:DHR) : September 6, 2017
finance.yahoo.com - September 6 at 12:23 AM |
| Danaher Corporation (DHR) Insider Sells $3,619,987.68 in Stock
www.americanbankingnews.com - September 5 at 7:23 PM |
| Danaher Corporation (DHR) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 2 at 6:30 PM |
| Danaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : September 1, 2017
finance.yahoo.com - September 1 at 6:11 PM |
 | Danaher To Present At Vertical Research Partners Industrial Conference - PR Newswire (press release)
www.prnewswire.com - August 31 at 10:50 PM |
| Danaher To Present At Vertical Research Partners Industrial Conference
finance.yahoo.com - August 31 at 5:48 PM |
| Analysts Expect Danaher Corporation (DHR) Will Post Quarterly Sales of $4.46 Billion
www.americanbankingnews.com - August 27 at 5:52 AM |
 | Danaher (DHR) Down 2.8% Since Earnings Report: Can It Rebound ... - Nasdaq
www.nasdaq.com - August 23 at 4:27 AM |
| Danaher (DHR) Down 2.8% Since Earnings Report: Can It Rebound?
finance.yahoo.com - August 21 at 5:32 PM |
| Danaher Corporation (DHR) Short Interest Update
www.americanbankingnews.com - August 16 at 1:54 AM |
| ETFs with exposure to Danaher Corp. : August 14, 2017
finance.yahoo.com - August 14 at 6:13 PM |
| See what the IHS Markit Score report has to say about Danaher Corp.
finance.yahoo.com - August 12 at 5:16 PM |
| Analysts Expect Danaher Corporation (NYSE:DHR) Will Announce Quarterly Sales of $4.46 Billion
www.americanbankingnews.com - August 9 at 7:52 AM |
| Danaher Corporation (DHR) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - August 8 at 8:40 PM |
| Danaher Enters Oversold Territory (DHR) - Nasdaq
www.nasdaq.com - August 8 at 5:36 PM |
| Zacks: Analysts Anticipate Danaher Corporation (DHR) to Post $0.95 EPS
www.americanbankingnews.com - August 7 at 8:32 AM |
| Acquisitions and Steady Business Operations Help Danaher
finance.yahoo.com - August 6 at 9:57 PM |
| Danaher Corporation (DHR) Earns "Buy" Rating from Jefferies Group LLC
www.americanbankingnews.com - August 6 at 12:34 AM |
| ETFs with exposure to Danaher Corp. : August 4, 2017
finance.yahoo.com - August 3 at 9:55 PM |
| Danaher Corporation (DHR) Insider Thomas Patrick Joyce, Jr. Sells 9,772 Shares
www.americanbankingnews.com - August 1 at 7:28 PM |
| Danaher Corporation (DHR) Upgraded at Zacks Investment Research
www.americanbankingnews.com - July 29 at 12:23 AM |
| Leucadia (LUK) Misses Q2 Earnings Estimates, Revenues Beat
finance.yahoo.com - July 28 at 7:54 PM |
| Danaher Corporation (NYSE:DHR) & Alliance HealthCare Services (AIQ) Head-To-Head Survey
www.americanbankingnews.com - July 26 at 6:29 PM |
 | After Disappointing Earnings, Is Danaher Corporation Still Worth Investing In? - Motley Fool
www.fool.com - July 26 at 6:28 PM |
| Danaher In Some Doldrums - Seeking Alpha
seekingalpha.com - July 26 at 6:28 PM |
| After Disappointing Earnings, Is Danaher Corporation Still Worth Investing In?
www.fool.com - July 25 at 7:52 AM |
| Danaher Corporation (DHR) Insider William King Sells 7,458 Shares
www.americanbankingnews.com - July 24 at 7:28 PM |
| Danaher Corporation (DHR) Director Linda P. Hefner Sells 10,578 Shares
www.americanbankingnews.com - July 24 at 7:28 PM |
| ETFs with exposure to Danaher Corp. : July 24, 2017
finance.yahoo.com - July 24 at 5:37 PM |
| FY2017 EPS Estimates for Danaher Corporation Increased by William Blair (DHR)
www.americanbankingnews.com - July 24 at 8:43 AM |
| Q3 2017 EPS Estimates for Danaher Corporation (DHR) Boosted by Analyst
www.americanbankingnews.com - July 24 at 7:34 AM |
| Danaher Corporation's (DHR) "Market Perform" Rating Reaffirmed at Wells Fargo & Company
www.americanbankingnews.com - July 22 at 5:50 PM |
| Danaher Corp. :DHR-US: Earnings Analysis: Q2, 2017 By the Numbers : July 21, 2017
finance.yahoo.com - July 21 at 7:40 PM |
| Danaher Corporation (DHR) Earns "Buy" Rating from Citigroup Inc.
www.americanbankingnews.com - July 21 at 4:52 PM |
| Edited Transcript of DHR earnings conference call or presentation 20-Jul-17 12:00pm GMT
finance.yahoo.com - July 21 at 1:03 AM |
| Danaher (DHR) Beats on Q2 Earnings & Revenues, Guides Up - Nasdaq
www.nasdaq.com - July 20 at 7:59 PM |
| Danaher Corporation's (DHR) CEO Thomas Patrick Joyce on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 20 at 7:59 PM |
| Danaher Reports Second Quarter 2017 Results
finance.yahoo.com - July 20 at 7:59 PM |
| Investor Network: Danaher Corporation to Host Earnings Call
finance.yahoo.com - July 20 at 7:59 PM |
| Danaher (DHR) Beats on Q2 Earnings & Revenues, Guides Up
finance.yahoo.com - July 20 at 7:59 PM |
Danaher Corporation (DHR) Chart for Sunday, September, 24, 2017
